Pr Jean-Yves Blay
- Spécialité
- Oncologue médical, expert sarcomes
- Titre
- Directeur Général
- Hôpital
- Centre Léon Bérard (Lyon)
- Derniers articles
-
- SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma. (1 avr. 2025)
- Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial. (25 mars 2025)
- Case Report: Metastatic succinate dehydrogenase-deficient gastrointestinal stromal tumor treated with chemotherapy and immune checkpoint inhibitor. (10 mars 2025)
- Detection of potential complications in cancer survivors after chemotherapy and development of a regional care network: the PASCA feasibility study. (4 mars 2025)
- Primary ovarian leiomyosarcoma: results from an analysis by the French Sarcoma Group (Ovarian SArcoma MAnagement - OSAMA Study). (6 févr. 2025)